281 related articles for article (PubMed ID: 21831227)
1. Prevention and treatment of alloantibody-mediated kidney transplant rejection.
Bartel G; Schwaiger E; Böhmig GA
Transpl Int; 2011 Dec; 24(12):1142-55. PubMed ID: 21831227
[TBL] [Abstract][Full Text] [Related]
2. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
3. The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection.
Ahmed T; Senzel L
J Clin Apher; 2012; 27(4):173-7. PubMed ID: 22411078
[TBL] [Abstract][Full Text] [Related]
4. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
[TBL] [Abstract][Full Text] [Related]
5. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
6. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of the broadly sensitized patient: what are the options?
Böhmig GA; Wahrmann M; Bartel G
Curr Opin Organ Transplant; 2011 Dec; 16(6):588-93. PubMed ID: 21971512
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in desensitization of crossmatch-positive kidney transplant recipients.
Morath C; Opelz G; Zeier M; Süsal C
Transplant Proc; 2012; 44(6):1648-51. PubMed ID: 22841236
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
[TBL] [Abstract][Full Text] [Related]
12. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
Kimball PM; King A
Clin Transpl; 2011; ():369-72. PubMed ID: 22755433
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
[TBL] [Abstract][Full Text] [Related]
14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
15. [Role of antibodies in kidney transplant].
Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
[TBL] [Abstract][Full Text] [Related]
17. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.
Stegall MD; Gloor JM
Curr Opin Organ Transplant; 2010 Feb; 15(1):8-10. PubMed ID: 19890210
[TBL] [Abstract][Full Text] [Related]
18. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
19. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
20. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S
Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]